MUSTANG BIO INC (MBIO)
US62818Q2030 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 3.52M | 6.23M | 75.70M | 109.60M | 97.80M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 237.00K | 3.88M | 0.00 | 100.00K | 0.00 | |||
| Other Current Assets | 2.29M | 1.23M | 3.20M | 2.00M | 1.70M | |||
| Total Current Assets | 6.05M | 11.35M | 78.90M | 111.70M | 99.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 513.00K | 4.81M | 12.30M | 12.10M | 9.10M | |||
| Other Non-Current Assets | 625.00K | 1.58M | 1.30M | 1.40M | 1.30M | |||
| Total Non-Current Assets | 1.14M | 6.40M | 13.50M | 13.50M | 10.40M | |||
| TOTAL ASSETS | 7.19M | 17.74M | 92.40M | 125.20M | 109.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 4.52M | 8.31M | 7.60M | 6.70M | 5.60M | |||
| Accounts Payable | 8.76M | 6.32M | 6.80M | 3.50M | 3.50M | |||
| Other Current Liabilities | 1.76M | 739.00K | 600.00K | 600.00K | 400.00K | |||
| Total Current Liabilities | 15.04M | 15.37M | 15.10M | 10.80M | 9.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 27.40M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 811.00K | 2.25M | 3.60M | 2.00M | 2.00M | |||
| Total Non-Current Liabilities | 811.00K | 2.25M | 31.00M | 2.00M | 2.00M | |||
| TOTAL LIABILITIES | 15.85M | 17.62M | 46.10M | 12.80M | 11.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -395.77M | -380.97M | -329.40M | -251.80M | -185.50M | |||
| Additional Paid In Capital | 387.11M | 380.50M | 374.50M | 359.90M | 276.00M | |||
| Common Shares | 3.00K | 592.00K | 1.10M | 4.30M | 7.90M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Shares Outstanding | 37.67M | 9.64M | 7.90M | 7.10M | 5.60M | |||
| Tangible Book Value per Share | -0.23 | 0.01 | 5.86 | 15.83 | 17.57 | |||
| Total Shareholders' Equity | -8.66M | 123.00K | 46.30M | 112.40M | 98.40M | |||
| TOTAL LIABILITIES AND EQUITY | 7.19M | 17.74M | 92.40M | 125.20M | 109.90M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.59 | N/A | N/A | |||
| Current Ratio | 0.40 | 0.74 | 5.23 | 10.34 | 10.47 | |||
| Return On Assets (ROA) | -325.54% | -290.85% | -83.91% | -53.01% | -54.61% | |||
| Return On Equity (ROE) | N/A | -41952.85% | -167.45% | -59.05% | -61.00% | |||
All data in USD , ROIC based on taxRate of 0.21